Cytek Biosciences, Inc. (CTKB) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.1
Day's range
$4.41

Cytek BioSciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 17.01 M $74.32 M   -0.97% 13.27%
TOPLINE CAPITAL MANAGEMENT, LLC 05/15/2026 7.06 M $30.87 M   -5.08% 5.51%
HHLR ADVISORS, LTD. 05/15/2026 6.66 M $29.09 M   0.00% 5.19%
MILLENNIUM MANAGEMENT LLC 05/15/2026 6.29 M $27.50 M   32.39% 4.91%
BOSTON PARTNERS 05/11/2026 5.80 M $25.36 M   15.86% 4.53%
05/15/2026 4.76 M $20.81 M   100.00% 3.72%
STATE STREET CORP 05/15/2026 4.12 M $18.02 M   -0.56% 3.22%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.83 M $12.39 M   1.55% 2.21%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 2.66 M $11.64 M   0.62% 2.08%
GOLDMAN SACHS GROUP INC 05/15/2026 2.34 M $10.25 M   31.00% 1.83%
05/08/2026 2.31 M $10.10 M   100.00% 1.80%
MORGAN STANLEY 05/15/2026 1.72 M $7.51 M   1.05% 1.34%
ROYCE & ASSOCIATES LP 05/12/2026 1.64 M $7.18 M   -2.97% 1.28%
BROWN CAPITAL MANAGEMENT LLC 05/14/2026 1.48 M $6.47 M   -28.58% 1.16%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 1.36 M $5.94 M   35.84% 1.06%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.10 M $4.83 M   0.92% 0.86%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.01 M $4.41 M   17.86% 0.79%
NORTHERN TRUST CORP 05/14/2026 1.01 M $4.39 M   4.97% 0.78%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 912.34 K $3.99 M   22.72% 0.71%
05/08/2026 882.11 K $3.85 M   195.55% 0.69%
CENTERBOOK PARTNERS LP 05/05/2026 729.87 K $3.19 M   100.00% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 717.01 K $3.13 M   100.00% 0.56%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 676.70 K $2.96 M   0.25% 0.53%
BANK OF NEW YORK MELLON CORP 05/05/2026 608.65 K $2.66 M   -4.59% 0.47%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 534.76 K $2.34 M   -19.82% 0.42%
CITADEL ADVISORS LLC 05/15/2026 471.39 K $2.06 M   182.69% 0.37%
HRT FINANCIAL LP 05/14/2026 414.05 K $1.81 M   -5.39% 0.32%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 398.99 K $1.74 M   -40.84% 0.31%
PUBLIC SECTOR PENSION INVESTMENT BOARD 05/13/2026 394.72 K $1.72 M   4.07% 0.31%
INVESCO LTD. 05/12/2026 388.23 K $1.70 M   -2.65% 0.30%
TUDOR INVESTMENT CORP ET AL 05/15/2026 320.72 K $1.40 M   100.00% 0.25%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 319.91 K $1.40 M   -11.55% 0.25%
JPMORGAN CHASE & CO 05/13/2026 299.09 K $1.29 M   -9.05% 0.23%
FMR LLC 05/15/2026 283.39 K $1.24 M   21.07% 0.22%
AMERICAN CENTURY COMPANIES INC 05/15/2026 281.68 K $1.23 M   -1.04% 0.22%
D. E. SHAW & CO., INC. 05/15/2026 260.13 K $1.14 M   -1.14% 0.20%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 257.29 K $1.12 M   -2.61% 0.20%
RHUMBLINE ADVISERS 05/12/2026 254.59 K $1.11 M   1.86% 0.20%
NUVEEN, LLC 04/30/2026 245.52 K $1.07 M   -3.27% 0.19%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 241.50 K $1.06 M   -18.31% 0.19%
AMERIPRISE FINANCIAL INC 05/15/2026 187.27 K $818.37 K   -7.44% 0.15%
UBS GROUP AG 05/05/2026 186.88 K $816.67 K   -59.38% 0.15%
LEGAL & GENERAL GROUP PLC 05/08/2026 182.86 K $799.10 K   -2.98% 0.14%
IEQ CAPITAL, LLC 05/15/2026 144.39 K $630.99 K   16.45% 0.11%
VOYA INVESTMENT MANAGEMENT LLC 05/12/2026 141.39 K $617.85 K   44.52% 0.11%
ALLIANCEBERNSTEIN L.P. 05/15/2026 141.05 K $712.29 K   0.00% 0.11%
PRUDENTIAL FINANCIAL INC 05/13/2026 117.60 K $513.90 K   10.05% 0.09%
FRANKLIN RESOURCES INC 05/13/2026 113.97 K $498.06 K   1,000.44% 0.09%
NUMERAI GP LLC 05/15/2026 112.46 K $491.45 K   -39.79% 0.09%
GSA CAPITAL PARTNERS LLP 05/08/2026 109.12 K $477.00 K   100.00% 0.09%

Cytek BioSciences Inc institutional Ownership - FAQ's

During the previous two years, 182 institutional investors and hedge funds held shares of Cytek BioSciences Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 17.01 M

Topline Capital Management, LLC: 7.06 M

HHLR ADVISORS, LTD.: 6.66 M

MILLENNIUM MANAGEMENT LLC: 6.29 M

Boston Partners: 5.8 M

STATE STREET CORP: 4.12 M

66.59% of Cytek BioSciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 102.33 M shares in the last 24 months. This purchase volume represents approximately $446.16 M in transactions.